• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment


81.4700 EUR 0.0300 0.04%

As of 11:35:00 ET on 09/17/2014.

Snapshot for BioMerieux (BIM)

Open: 81.6000 Day's Range: 80.2600 - 81.6000 Volume: 16,836
Previous Close: 81.5000 52wk Range: 70.6500 - 83.9500 1-Yr Rtn: +13.27%

Stock Chart for BIM

No chart data available.
  • BIM:FP 81.4700
  • 1D
  • 1M
  • 1Y
Interactive BIM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIM

Current P/E Ratio (ttm) 23.5462
Estimated P/E(12/2014) 23.4042
Relative P/E vs. CAC 0.9115
Earnings Per Share (EUR) (ttm) 3.4600
Est. EPS (EUR) (12/2014) 3.4810
Est. PEG Ratio 2.6005
Market Cap (M EUR) 3,214.30
Shares Outstanding (M) 39.45
30 Day Average Volume 14,818
Price/Book (mrq) 2.6826
Price/Sale (ttm) 1.9940
Dividend Indicated Gross Yield 1.23%
Cash Dividend (EUR) 1.0000
Dividend Ex-Date 06/03/2014
5 Year Dividend Growth 4.30%
Next Earnings Announcement 03/19/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIM

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for BIM

BioMerieux designs, develops, manufactures, and markets systems in the field of in vitro diagnostics for medical and industrial applications. The Company is specialized in the diagnosis of infectious diseases and pathologies. BioMerieux is also active in the analysis of food, pharmaceuticals and environmental samples to determine their microbiological quality.

Jean-Luc BelingardChairmanAlexandre MerieuxChief Executive Officer
Henri ThomassonChief Financial OfficerMark MillerChief Medical Officer
More Company Profile & Key Executives for BIM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil